CRISPR-Based TB Test Detects Infection From Tongue Swabs
The test showed 74% detection rate in tongue swabs compared to 56% with traditional testing methods that rely on difficult-to-collect sputum samples.
Read MorePosted by Edisource Vendor | Sep 17, 2025 | Tuberculosis |
The test showed 74% detection rate in tongue swabs compared to 56% with traditional testing methods that rely on difficult-to-collect sputum samples.
Read MorePosted by Edisource Vendor | Sep 16, 2025 | Point-of-Care |
The Fast PCR Mini Respiratory Panel simultaneously detects Flu A, Flu B, RSV, and SARS-CoV-2 from nasal swab specimens.
Read MorePosted by Edisource Vendor | Sep 11, 2025 | POC Rapid Assays |
The phase 2B trial of vapendavir will use bioMérieux’s Biofire Spotfire panel—a CLIA-waived molecular test that detects rhinovirus—to confirm infections in COPD patients.
Read MorePosted by Edisource Vendor | Sep 11, 2025 | Molecular Diagnostics |
A new AI-powered platform provides meal suggestions, ingredient substitutions, and meal planning guidance to help patients avoid their identified trigger foods.
Read MorePosted by Edisource Vendor | Sep 8, 2025 | Tuberculosis |
Seattle startup will use funding to develop urine-based tuberculosis test using engineered NovoBodies technology for low-resource settings.
Read More